← Back to Search

Non-Invasive Respiratory Monitoring for Cerebral Palsy

N/A
Recruiting
Led By Tariq Rahman, PhD
Research Sponsored by Nemours Children's Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Subjects should have cerebral palsy a GMFCS levels IV, V
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

Study Summary

This trial aims to improve breathing in those with cerebral palsy, using a non-invasive sensor to detect respiratory distress and investigate the link with scoliosis.

Who is the study for?
This trial is for children with severe cerebral palsy, specifically those who are classified at GMFCS levels IV or V, indicating they have significant physical limitations. The study aims to help detect respiratory issues and understand the link between lung function and scoliosis in these patients.Check my eligibility
What is being tested?
The trial is testing a new non-invasive respiratory sensor called pneuRIP. It's designed as a screening tool to identify breathing difficulties in kids with cerebral palsy and to explore how their lung health relates to spine curvature caused by scoliosis.See study design
What are the potential side effects?
Since pneuRIP is a non-invasive sensor used for monitoring purposes, there are no direct side effects associated with its use. However, participation may involve some discomfort due to wearing the device.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Presence of pulmonary dysfunction

Trial Design

1Treatment groups
Experimental Treatment
Group I: cerebral palsy groupExperimental Treatment1 Intervention
Respiratory sensor will measure breathing in patients with Cerebral palsy

Find a Location

Who is running the clinical trial?

Nemours Children's ClinicLead Sponsor
124 Previous Clinical Trials
17,881 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,701 Previous Clinical Trials
7,506,600 Total Patients Enrolled
7 Trials studying Cerebral Palsy
823 Patients Enrolled for Cerebral Palsy
Tariq Rahman, PhDPrincipal InvestigatorPrincipal Research Engineer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial still recruiting participants?

"The information on clinicaltrials.gov reveals that this trial is actively recruiting participants. It made its first appearance on October 2nd 2023 and was most recently updated November 27th of the same year."

Answered by AI

Is the minimum age requirement for this trial eighteen or older?

"This study is exclusively for minors aged 5-17. It is one of 205 total trials catering to younger patients, while 28 medical studies are aimed at individuals over 65 years old."

Answered by AI

What qualifications must potential participants possess to join this medical study?

"This research is seeking 250 volunteers, aged between 5 and 17 years old, with cerebral palsy at GMFCS levels IV or V."

Answered by AI

What is the proposed number of participants in this clinical trial?

"Affirmative. According to the information published on clinicaltrials.gov, this trial is actively seeking 250 participants from 1 medical centre. The initial posting occurred on October 2nd 2023 and was recently updated on November 27th 2023."

Answered by AI
~150 spots leftby Feb 2025